Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1949 1
1959 1
1960 2
1961 2
1962 4
1963 5
1964 8
1965 1
1966 1
1968 1
1971 2
1972 1
1973 2
1974 3
1975 1
1976 4
1977 2
1978 3
1979 4
1980 4
1981 2
1982 1
1983 5
1984 1
1985 2
1986 3
1987 3
1988 1
1989 6
1990 1
1992 3
1993 6
1994 5
1995 8
1996 3
1997 12
1998 10
1999 8
2000 7
2001 5
2002 7
2003 3
2004 3
2005 4
2006 2
2007 4
2008 1
2009 6
2010 3
2011 7
2012 5
2013 7
2014 6
2015 1
2016 2
2017 7
2018 14
2019 5
2020 8
2021 8
2022 10
2023 9
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Patel N, Yancopoulos GD, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB; NOTUS Study Investigators. Bhatt SP, et al. N Engl J Med. 2024 Jun 27;390(24):2274-2283. doi: 10.1056/NEJMoa2401304. Epub 2024 May 20. N Engl J Med. 2024. PMID: 38767614 Clinical Trial.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Congenital disorders of the thyroid: hypo/hyper.
Péter F, Muzsnai A. Péter F, et al. Pediatr Clin North Am. 2011 Oct;58(5):1099-115, ix. doi: 10.1016/j.pcl.2011.07.002. Pediatr Clin North Am. 2011. PMID: 21981951 Review.
Light- and magnetically actuated FePt microswimmers.
Kadiri VM, Günther JP, Kottapalli SN, Goyal R, Peter F, Alarcón-Correa M, Son K, Barad HN, Börsch M, Fischer P. Kadiri VM, et al. Among authors: peter f. Eur Phys J E Soft Matter. 2021 Jun 2;44(6):74. doi: 10.1140/epje/s10189-021-00074-1. Eur Phys J E Soft Matter. 2021. PMID: 34076781 Free PMC article.
Congenital disorders of the thyroid: hypo/hyper.
Péter F, Muzsnai A. Péter F, et al. Endocrinol Metab Clin North Am. 2009 Sep;38(3):491-507. doi: 10.1016/j.ecl.2009.07.002. Endocrinol Metab Clin North Am. 2009. PMID: 19717001 Review.
"Reversible" Alzheimer's disease?
Peter F, Susanne J, Margareta H, Silvia W, Wolfgang K, Thomas L, Heinz TK. Peter F, et al. J Am Geriatr Soc. 2011 Jun;59(6):1137-8. doi: 10.1111/j.1532-5415.2011.03437.x. J Am Geriatr Soc. 2011. PMID: 21668917 No abstract available.
266 results